GUILIN SANJIN PHAR revenue breakdown overview

GUILIN SANJIN PHAR revenue for the last year amounted to 2.17 B CNY, the most of which — 2.10 B CNY — came from its highest performing source at the moment, Chinese Patent Medicine (Industry), the year earlier bringing 1.77 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought GUILIN SANJIN PHAR 2.16 B CNY, and the year before that — 1.95 B CNY.